Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph P Vacca

Showing results (61-70 of 84) with videos related to

Pageof 9
Sort By:
Bioorganic & Medicinal Chemistry Letters|March 20, 2010
Identification of potent, highly constrained CGRP receptor antagonistsCraig A Stump, Ian M Bell, Rodney A Bednar, et al.
Bioorganic & Medicinal Chemistry Letters|August 17, 2005
A series of 5-(5,6)-dihydrouracil substituted 8-hydroxy-[1,6]naphthyridine-7-carboxylic acid 4-fluorobenzylamide inhibitors of HIV-1 integrase and viral replication in cellsMark W Embrey, John S Wai, Timothy W Funk, et al.
Bioorganic & Medicinal Chemistry Letters|May 8, 2007
Design, synthesis, and SAR of macrocyclic tertiary carbinamine BACE-1 inhibitorsStacey R Lindsley, Keith P Moore, Hemaka A Rajapakse, et al.
Bioorganic & Medicinal Chemistry Letters|October 10, 2006
Identification of novel, orally bioavailable spirohydantoin CGRP receptor antagonistsIan M Bell, Rodney A Bednar, John F Fay, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of MK-1220: A Macrocyclic Inhibitor of Hepatitis C Virus NS3/4A Protease with Improved Preclinical Plasma ExposureMichael T Rudd, John A McCauley, John W Butcher, et al.
Bioorganic & Medicinal Chemistry Letters|September 28, 2010
Potent and selective HIV-1 ribonuclease H inhibitors based on a 1-hydroxy-1,8-naphthyridin-2(1H)-one scaffoldPeter D Williams, Donnette D Staas, Shankar Venkatraman, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 13, 2010
Pharmacological properties of MK-3207, a potent and orally active calcitonin gene-related peptide receptor antagonistChristopher A Salvatore, Eric L Moore, Amy Calamari, et al.
Journal of Medicinal Chemistry|September 25, 2008
Discovery and X-ray crystallographic analysis of a spiropiperidine iminohydantoin inhibitor of beta-secretaseJames C Barrow, Shaun R Stauffer, Kenneth E Rittle, et al.
Bioorganic & Medicinal Chemistry Letters|May 25, 2005
P2 pyridine N-oxide thrombin inhibitors: a novel peptidomimetic scaffoldPhilippe G Nantermet, Christopher S Burgey, Kyle A Robinson, et al.
Antimicrobial Agents and Chemotherapy|May 23, 2012
MK-5172, a selective inhibitor of hepatitis C virus NS3/4a protease with broad activity across genotypes and resistant variantsVincenzo Summa, Steven W Ludmerer, John A McCauley, et al.
Pageof 9

Showing results (61-70 of 84) with videos related to

Sort By:
Pageof 9
Bioorganic & Medicinal Chemistry Letters|March 20, 2010
Identification of potent, highly constrained CGRP receptor antagonistsCraig A Stump, Ian M Bell, Rodney A Bednar, et al.
Bioorganic & Medicinal Chemistry Letters|August 17, 2005
A series of 5-(5,6)-dihydrouracil substituted 8-hydroxy-[1,6]naphthyridine-7-carboxylic acid 4-fluorobenzylamide inhibitors of HIV-1 integrase and viral replication in cellsMark W Embrey, John S Wai, Timothy W Funk, et al.
Bioorganic & Medicinal Chemistry Letters|May 8, 2007
Design, synthesis, and SAR of macrocyclic tertiary carbinamine BACE-1 inhibitorsStacey R Lindsley, Keith P Moore, Hemaka A Rajapakse, et al.
Bioorganic & Medicinal Chemistry Letters|October 10, 2006
Identification of novel, orally bioavailable spirohydantoin CGRP receptor antagonistsIan M Bell, Rodney A Bednar, John F Fay, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of MK-1220: A Macrocyclic Inhibitor of Hepatitis C Virus NS3/4A Protease with Improved Preclinical Plasma ExposureMichael T Rudd, John A McCauley, John W Butcher, et al.
Bioorganic & Medicinal Chemistry Letters|September 28, 2010
Potent and selective HIV-1 ribonuclease H inhibitors based on a 1-hydroxy-1,8-naphthyridin-2(1H)-one scaffoldPeter D Williams, Donnette D Staas, Shankar Venkatraman, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 13, 2010
Pharmacological properties of MK-3207, a potent and orally active calcitonin gene-related peptide receptor antagonistChristopher A Salvatore, Eric L Moore, Amy Calamari, et al.
Journal of Medicinal Chemistry|September 25, 2008
Discovery and X-ray crystallographic analysis of a spiropiperidine iminohydantoin inhibitor of beta-secretaseJames C Barrow, Shaun R Stauffer, Kenneth E Rittle, et al.
Bioorganic & Medicinal Chemistry Letters|May 25, 2005
P2 pyridine N-oxide thrombin inhibitors: a novel peptidomimetic scaffoldPhilippe G Nantermet, Christopher S Burgey, Kyle A Robinson, et al.
Antimicrobial Agents and Chemotherapy|May 23, 2012
MK-5172, a selective inhibitor of hepatitis C virus NS3/4a protease with broad activity across genotypes and resistant variantsVincenzo Summa, Steven W Ludmerer, John A McCauley, et al.
Pageof 9